// App-Quantinova.ai

OA0123 : Identifying allergic children with severe adverse events during oral peanut challenges in the LEAP studies by assessing basophil activation

Researchers

Presenter

  • Santos AF

Principal Investigators

  • Du Toit G

  • O'Rourke C

  • Becares N

  • Couto-Francisco N

  • Radulovic S

  • Khaleva E

  • Harris KM

  • Larson D

  • Sayre P

  • Bahnson HT

  • Lack G

Medical Centers

  • Department of Women and Children's Health (Pediatric Allergy), King's College London, London, United Kingdom

  • Department of Immunobiology, Kings College London, London, United Kingdom

  • Children's Allergy Service, Guy's and St Thomas’ Hospital, London, United Kingdom

  • Asthma UK Centre in Allergic Mechanisms of Asthma, London, United Kingdom

  • Immune Tolerance Network, Bethesda, United States of America

  • Benaroya Research Institute, Seattle, WA, United States

  • Immune Tolerance Network, Bethesda, United States of America

  • Division of Hematology/Oncology and Division of Geriatrics, University of California, San Francisco, San Francisco, CA

  • Immune Tolerance Network, San Francisco, United States

Locations

  • United Kingdom

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • Immunoglobulin E

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved